| Product NDC: | 25021-157 |
| Proprietary Name: | Vancomycin |
| Non Proprietary Name: | vancomycin hydrochloride |
| Active Ingredient(s): | 5 g/100mL & nbsp; vancomycin hydrochloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 25021-157 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA200837 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120920 |
| Package NDC: | 25021-157-99 |
| Package Description: | 1 BOTTLE in 1 CARTON (25021-157-99) > 100 mL in 1 BOTTLE |
| NDC Code | 25021-157-99 |
| Proprietary Name | Vancomycin |
| Package Description | 1 BOTTLE in 1 CARTON (25021-157-99) > 100 mL in 1 BOTTLE |
| Product NDC | 25021-157 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | vancomycin hydrochloride |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20120920 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | VANCOMYCIN HYDROCHLORIDE |
| Strength Number | 5 |
| Strength Unit | g/100mL |
| Pharmaceutical Classes | Glycopeptide Antibacterial [EPC],Glycopeptides [Chemical/Ingredient] |